Eprenetapopt (APR-246) and azacitidine in TP53-mutant myelodysplastic syndromes

David A. Sallman, Amy E. DeZern, Guillermo Garcia-Manero, David P. Steensma, Gail J. Roboz, Mikkael A. Sekeres, Thomas Cluzeau, Kendra L. Sweet, Amy McLemore, Kathy L. McGraw, John Puskas, Ling Zhang, Jiqiang Yao, Qianxing Mo, Lisa Nardelli, Najla H. Al Ali, Eric Padron, Greg Korbel, Eyal C. Attar, Hagop M. KantarjianJeffrey E. Lancet, Pierre Fenaux, Alan F. List, Rami S. Komrokji

Research output: Contribution to journalArticlepeer-review

277 Scopus citations

Fingerprint

Dive into the research topics of 'Eprenetapopt (APR-246) and azacitidine in TP53-mutant myelodysplastic syndromes'. Together they form a unique fingerprint.

Medicine & Life Sciences